Dolutegravir with boosted darunavir as treatment simplification for treatment-experienced HIV patients with multiple mutations

Int J STD AIDS. 2019 Oct;30(12):1214-1215. doi: 10.1177/0956462419857003.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • CD4 Lymphocyte Count
  • Darunavir / therapeutic use*
  • Female
  • HIV Infections / drug therapy*
  • HIV Integrase Inhibitors / therapeutic use*
  • HIV Protease Inhibitors / therapeutic use*
  • Heterocyclic Compounds, 3-Ring / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Mutation
  • Oxazines
  • Piperazines
  • Pyridones
  • Retrospective Studies
  • Reverse Transcriptase Inhibitors
  • Treatment Outcome
  • Viral Load / drug effects

Substances

  • HIV Integrase Inhibitors
  • HIV Protease Inhibitors
  • Heterocyclic Compounds, 3-Ring
  • Oxazines
  • Piperazines
  • Pyridones
  • Reverse Transcriptase Inhibitors
  • dolutegravir
  • Darunavir